Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.

PloS One
Pauline ChasteThomas Bourgeron

Abstract

Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and c...Continue Reading

References

Jan 16, 1997·The New England Journal of Medicine·A Brzezinski
Jun 17, 1998·Psychiatry and Clinical Neurosciences·M TairaH Sasaki
Feb 3, 1999·Journal of Paediatrics and Child Health·L M PatzoldB J Tonge
Apr 12, 2002·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Lorna WingMichael Larcombe
Apr 17, 2002·Science·Howard M CannL Luca Cavalli-Sforza
Mar 8, 2003·Journal of Neuroendocrinology·J Arendt
Jun 14, 2003·Journal of Child and Adolescent Psychopharmacology·E Juulia PaavonenLennart von Wendt
Jun 4, 2004·Developmental Medicine and Child Neurology·Luci Wiggs, Gregory Stores
Aug 5, 2004·Neuropsychobiology·Pekka TaniTarja Porkka-Heiskanen
Apr 18, 2006·Journal of Autism and Developmental Disorders·Hiie AllikHans Smedje
Aug 22, 2006·Child: Care, Health and Development·J Garstang, M Wallis
Nov 8, 2006·Autism : the International Journal of Research and Practice·Dougal Julian HareKate Evershed
Dec 29, 2006·Molecular Pharmacology·G Enrico RovatiRichard R Neubig
May 17, 2007·Molecular Psychiatry·J MelkeT Bourgeron
Jan 10, 2008·Journal of Child Neurology·Ivy M AndersenBeth A Malow
May 22, 2008·British Journal of Pharmacology·R JockersP Delagrange
Jun 3, 2008·PLoS Genetics·Alun R Barnard, Patrick M Nolan
Jan 15, 2009·Structure·Michael A Hanson, Raymond C Stevens
May 22, 2009·Nature·Daniel M RosenbaumBrian K Kobilka
Aug 25, 2009·Molecular and Cellular Neurosciences·Ellen GrünewaldPippa A Thomson

❮ Previous
Next ❯

Citations

Oct 17, 2013·International Journal of Molecular Sciences·Sylvie TordjmanJulie Vernay-Leconte
Dec 6, 2011·Breast Cancer Research and Treatment·Sandra L DemingWei Zheng
Jan 18, 2012·European Journal of Pediatrics·Hilde Olivié
Apr 5, 2011·Current Opinion in Psychiatry·Valsamma Eapen
Oct 12, 2013·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Martha R Herbert, Cindy Sage
Sep 11, 2012·Experimental Eye Research·Gianluca TosiniP Michael Iuvone
May 11, 2015·Brain & Development·Zhiliang YangTakanori Yamagata
Jun 30, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·K DietrichP Kovacs
May 28, 2011·Journal of Pineal Research·Pauline ChasteThomas Bourgeron
Jun 18, 2016·British Journal of Pharmacology·Ralf JockersDarius P Zlotos
May 29, 2013·International Journal of Molecular Sciences·Di Yan LiQing Zhu
Oct 28, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dawei LiJoel Gelernter
Jul 15, 2017·British Journal of Pharmacology·Erika CeconRalf Jockers
Sep 23, 2018·Journal of Pineal Research·Rüdiger Hardeland
Aug 17, 2019·G3 : Genes - Genomes - Genetics·Elsa DenkerDaniel J Macqueen
Nov 5, 2019·Current Pharmaceutical Design·Luciana PinatoSanseray da Silveira Cruz-Machado
Feb 23, 2019·Frontiers in Psychiatry·Anna MaruaniRichard Delorme
Apr 16, 2019·Biological Research for Nursing·Ann E E JohanssonBernie Devlin
Dec 6, 2019·Frontiers in Endocrinology·Lei LiuRalf Jockers
May 16, 2017·Current Psychiatry Reports·Margaret C SoudersJennifer Pinto-Martin
Dec 12, 2018·Nature Reviews. Endocrinology·Angeliki Karamitri, Ralf Jockers
Mar 15, 2015·The Journal of Biological Chemistry·Maud KamalRalf Jockers
Jan 7, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Althea Robinson Shelton, Beth Malow
Sep 20, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Li-Kun YangYa-Xiong Tao
Jul 19, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhou-Yue WuFeng Han
Oct 26, 2021·Frontiers in Cellular Neuroscience·Lap Hang Tse, Yung Hou Wong

❮ Previous
Next ❯

Methods Mentioned

BETA
competition binding
competition bindings
PCR
PCRs
FACS

Software Mentioned

Actiwatch Activity and Sleep Analysis

Related Concepts

Related Feeds

Asperger Syndrome

Asperger syndrome (AS), also known as Asperger's, is a developmental disorder characterized by significant difficulties in social interaction and nonverbal communication, along with restricted and repetitive patterns of behavior and interests. Discover the latest research on Asperger syndrome here.

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Related Papers

International Journal of Molecular Sciences
Di Yan LiQing Zhu
Best Practice & Research. Clinical Endocrinology & Metabolism
Elmar Peschke, Eckhard Mühlbauer
Annals of Medicine
Karsten MüssigAndreas Fritsche
© 2021 Meta ULC. All rights reserved